Filing Details
- Accession Number:
- 0001214659-17-005551
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-07 18:56:38
- Reporting Period:
- 2017-09-07
- Accepted Time:
- 2017-09-07 18:56:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1316175 | Anthera Pharmaceuticals Inc | ANTH | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1120362 | F Paul Truex | 25801 Industrial Blvd Suite B Hayward CA 94545 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-09-07 | 5,000 | $1.34 | 16,793 | No | 4 | P | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Trust |
Footnotes
- The Reporting Person acquired the shares in the open market and through the 2005 Truex Family Trust u/d/t April 20, 2005. Shares have been adjusted to reflect the issuer's 1-for-8 reverse stock split effectuated on April 28, 2017.
Billionaire Hedge Funds
